Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5372927013 | Bimekizumab 160 mg/mL solution for injection | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5372928015 | Product containing precisely bimekizumab 160 milligram/1 milliliter conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bimekizumab 160 mg/mL solution for injection | Has manufactured dose form | Solution for injection | true | Inferred relationship | Some | ||
| Bimekizumab 160 mg/mL solution for injection | Has precise active ingredient | Bimekizumab (substance) | true | Inferred relationship | Some | 1 | |
| Bimekizumab 160 mg/mL solution for injection | Has basis of strength substance (attribute) | Bimekizumab (substance) | true | Inferred relationship | Some | 1 | |
| Bimekizumab 160 mg/mL solution for injection | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Bimekizumab 160 mg/mL solution for injection | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Bimekizumab 160 mg/mL solution for injection | Is a | Product containing only bimekizumab in parenteral dose form (medicinal product form) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR